Blogs

Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1

By Aesthetic Multispecialty Society posted Jul 14, 2020 06:53 AM

  
.
0 comments
0 views

Permalink